Suppressing activity of tributyrin on hepatocarcinogenesis is associated with inhibiting the p53-CRM1 interaction and changing the cellular compartmentalization of p53 protein

Hepatocellular carcinoma (HCC), an aggressive and the fastest growing life-threatening cancer worldwide, is often diagnosed at intermediate or advanced stages of the disease, which substantially limits therapeutic approaches for its successful treatment. This indicates that the prevention of hepatoc...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Ortega, Juliana F., de Conti, Aline, Tryndyak, Volodymyr, Furtado, Kelly S., Heidor, Renato, Horst, Maria Aderuza, Fernandes, Laura Helena Gasparini, Tavares, Paulo Eduardo Latorre Martins, Pogribna, Marta, Shpyleva, Svitlana, Beland, Frederick A., Pogribny, Igor P., Moreno, Fernando Salvador
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2016
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5029705/
https://ncbi.nlm.nih.gov/pubmed/27013579
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8248
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars